Investigating the association between radiological images and the pathology of rectal cancer treated with neoadjuvant chemotherapy

被引:2
|
作者
Morohashi, Satoko [1 ]
Morohashi, Hajime [2 ]
Seino, Hiroko [3 ]
Yoshizawa, Tadashi [1 ]
Haga, Toshihiro [1 ]
Goto, Shintaro [1 ]
Wu, Yunyan [1 ]
Sakamoto, Yoshiyuki [2 ]
Hakamada, Kenichi [2 ]
Kijima, Hiroshi [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Pathol & Biosci, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Dept Gastroenterol Surg, Grad Sch Med, Hirosaki, Aomori 0368562, Japan
[3] Aomori Natl Hosp, Dept Radiol, Namioka, Aomori 0381331, Japan
关键词
rectal cancer; neoadjuvant chemotherapy; radiological images; pathology; reduction ratio; PREOPERATIVE CHEMORADIOTHERAPY; TUMOR-REGRESSION; CHEMORADIATION; RADIOTHERAPY; CARCINOMA; THERAPY;
D O I
10.3892/mco.2019.1931
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In patients with rectal cancer treated with neoadjuvant chemotherapy (NAC), differences are often observed between high and low radiological image reduction effects. It may be suggested that high radiological image reduction indicates a beneficial response to chemotherapy. However, the pathological investigation of the differences between high and low radiological cancer volume reduction cases remains limited. In the current study, a total of 50 patients with rectal cancer, treated with NAC, were examined. The approximate pathological primary cancer area and the radiological cancer volume reduction ratio were measured using CT and/or MRI imaging and the donut-shaped measurement method. Immunostaining of cytokeratin AE1/AE3 was performed to quantitatively measure the cancer cell mass in the largest section of rectal cancer. Cytokeratin AE1/AE3-stained area (P=0.04), mitosis (P=0.0027) and radiological donut-shaped images after NAC (P=0.010) were lower in the high radiological cancer volume reduction ratio group compared with the low radiological cancer volume reduction ratio group. These findings indicate that the radiological images had some ability to determine the treatment effect and clinicopathological characteristics of patients with rectal cancer treated with NAC.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 50 条
  • [1] Adjuvant Chemotherapy in the neoadjuvant treated for Rectal Cancer
    Reibetanz, J.
    Germer, C. T.
    [J]. CHIRURG, 2015, 86 (07): : 710 - 710
  • [2] Association between chemotherapy for surgically treated rectal cancer and second primary endometrial cancer
    Gao, Tianyu
    Liu, Wenlu
    Ma, Dongjiang
    Huang, Weipeng
    Zhang, Dongyan
    Wei, Qiuya
    Yu, Congcong
    Chen, Minxue
    Fan, Yong
    Wang, Chen
    Du, Peng
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Association Between Neoadjuvant Chemoradiation Therapy and Hematologic Toxicity During Adjuvant Chemotherapy in Rectal Cancer
    Newman, N. B.
    Sidhu, M. K.
    Baby, R.
    Moss, R. A.
    Rezac, C.
    Poplin, E.
    Patel, N. M.
    Jabbour, S. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E168 - E168
  • [4] Association of adjuvant chemotherapy with clinical outcomes in patients treated with neoadjuvant chemoradiation for locally advanced rectal cancer.
    Vickers, Michael M.
    Mercer, Jamison
    Kumar, Aalok
    Gresham, Gillian
    Goodwin, Rachel Anne
    Jiang, Maria
    Tang, Patricia A.
    Raissouni, Soundouss
    Powell, Erin Diana
    Hiller, Julie A. Price
    Monzon, Jose Gerard
    Cheung, Winson Y.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Extending neoadjuvant chemotherapy in rectal cancer
    Rosello, Susana
    Cervantes, Andres
    [J]. LANCET ONCOLOGY, 2015, 16 (08): : 880 - 881
  • [6] CONCORDANCE BETWEEN RADIOLOGICAL AND PATHOLOGICAL RESPONSE IN AXILLARY LYMPH NODES IN PATIENTS WITH BREAST CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Servitja Tormo, S.
    Garrigos Cubells, L.
    Rodriguez Arana, A.
    Sabadell Mercadal, D.
    Corominas, J. M.
    Martinez-Garcia, M.
    Gonzalez Maeso, I.
    Martos Cardenas, T.
    Albanell, J.
    Trias Bes, I. Tusquets
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [7] EVALUATION OF NEOADJUVANT TREATMENT OF RECTAL CANCER - PATHOLOGY
    Nagtegaal, I. D.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : I16 - I17
  • [8] Pathology of prostate cancer treated with neoadjuvant chemotherapy: Features predictive of clinical outcome
    True, LD
    O'Brien, CA
    Higano, CS
    Huang, A
    Beer, TM
    [J]. MODERN PATHOLOGY, 2006, 19 : 165A - 165A
  • [9] Pathology of prostate cancer treated with neoadjuvant chemotherapy: Features predictive of clinical outcome
    True, LD
    O'Brien, CA
    Higano, CS
    Huang, A
    Beer, TM
    [J]. LABORATORY INVESTIGATION, 2006, 86 : 165A - 165A
  • [10] Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection
    Dossa, Fahima
    Acuna, Sergio A.
    Rickles, Aaron S.
    Berho, Mariana
    Wexner, Steven D.
    Quereshy, Fayez A.
    Baxter, Nancy N.
    Chadi, Sami A.
    [J]. JAMA ONCOLOGY, 2018, 4 (07) : 930 - 937